Cell cycle-tailored targeting of metastatic melanoma: Challenges and opportunities.

about

Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance.

P2860

Q55424318-D6E8F0C0-AA13-4D04-991B-D87E7690EB4A

P2860

Cell cycle-tailored targeting of metastatic melanoma: Challenges and opportunities.

Item

http://www.wikidata.org/entity/Q39191984

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cell cycle-tailored targeting of metastatic melanoma: Challenges and opportunities.

@en

Cell cycle-tailored targeting of metastatic melanoma: Challenges and opportunities.

@nl

type

Item

label

Cell cycle-tailored targeting of metastatic melanoma: Challenges and opportunities.

@en

Cell cycle-tailored targeting of metastatic melanoma: Challenges and opportunities.

@nl

prefLabel

Cell cycle-tailored targeting of metastatic melanoma: Challenges and opportunities.

@en

Cell cycle-tailored targeting of metastatic melanoma: Challenges and opportunities.

@nl

P1476

Cell cycle-tailored targeting of metastatic melanoma: Challenges and opportunities

@en

P2093

Brian Gabrielli

http://www.w3.org/2001/XMLSchema#string

Nikolas K Haass

http://www.w3.org/2001/XMLSchema#string

P2860

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

Combination Therapies to Inhibit the RAF/MEK/ERK Pathway in Melanoma: We are not Done Yet

Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.

Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

Drug penetration in solid tumours

Visualizing spatiotemporal dynamics of multicellular cell-cycle progression

ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress.

Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.

P304

649-655

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EXD.13303

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nikolas K. Haass

B Gabrielli

P577

2017-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28109167

http://www.w3.org/2001/XMLSchema#string

Cell cycle-tailored targeting of metastatic melanoma: Challenges and opportunities.

about

P2860

P2860

Cell cycle-tailored targeting of metastatic melanoma: Challenges and opportunities.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698